Mumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro ...

Mumbai-based Pharma major Cipla Ltd was imposed a GST penalty of ... been passed by the GST Authority on the contention that the company has claimed inadmissible transitional credit on education ...

Pharmaceutical major Cipla on Tuesday reported a 49 per cent year-on-year (YoY) increase in its consolidated net profit for the December quarter (Q3 FY25) at Rs 1,574.6 crore, from Rs 1,068.5 crore ...

Mumbai: Cipla has announced the appointment of Achin Gupta, Chief Executive Officer – One India Business (SMP) as the Global ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Cipla, one of India's largest drugmaker by sales, reported a bigger-than-expected third-quarter profit on Tuesday, helped by strong demand, especially in the key North American market. The company's ...

During the year, the Company issued and allotted 2,16,469 equity shares of Rs. 2/- each to its employees under the Employee Stock Option Scheme 2013-A and the Cipla Employee StockAppreciation ...

For the first nine months of FY25, Cipla's EBITDA margin stood at 26.9%, already above its full-year guidance of 24.5% to 25.5%.

Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by strong domestic demand, and said the U.S. freezing aid for some drug ...

Cipla expects to end the ongoing fiscal year exceeding its margin guidance, managing director and global CEO Umang Vohra said, as the Mumbai-based ... profitability. The company reported an ...

If you own or are associated with Cipla Ltd and want to update your company’s information, please click here. Medindia offers the most extensive free access search platform, delivering vital ...

That more than made up for a 1% drop in sales in North America, Cipla's second-biggest market, and helped the company's total revenue climb 7.1% to 70.73 billion rupees, surpassing market ...